MAPT and supranuclear palsy, progressive, 1: On the other hand, to date, there are no pathological criteria to differentiate the phenotypes of PSP, but it seems clear that they depend on the different tau load and distribution within encephalic regions and to the different patterns of cellular tau pathologies (10).